89. リンパ脈管筋腫症 Lymphangioleiomyomatosis Clinical trials / Disease details


臨床試験数 : 38 薬物数 : 38 - (DrugBank : 15) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 118

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02484664
(ClinicalTrials.gov)
June 15, 201625/6/2015COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSCCOLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSCLymphangioleiomyomatosis (LAM)Drug: CelecoxibBrigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI)Completed18 Years70 YearsFemale12Phase 2United States